Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
China says U.S. firms should lobby Washington over trade as South Korea union warns of American job losses

2018-07-12 japantimes.co.jp
BEIJING – China tried to step up pressure on Washington in their growing tariff war Thursday by suggesting U.S. companies lobby American leaders, while a South Korean union warned President Donald Trump’s threat of higher auto import duties could lead to job losses in Alabama.
HYUO HYUP HYUD

0
India, South Korea aim to more than double trade to $50 billion

2018-07-11 moneycontrol
India and South Korea signed 11 agreements on Tuesday to expand business ties and more than double mutual trade to $50 billion by 2030, a day after the premiers of the two countries launched a Samsung mobile phone factory near Delhi.
HYUO HYUP HYUD

0
Asian markets decline after tariff list news; China stocks take a hit

2018-07-11 theedgemarkets
(July 11): Trade developments returned to focus during Asian trade on Wednesday, with major markets in the region falling following the release of a list of an additional $200 billion in Chinese goods on which the U.S. is considering imposing tariffs.
HYUO 7018 CME TM 7203 BC94 TYT SMSN HYUP TOYOF HYUD SMSD

1
WABCO (WBC) Signs Deal With Hyundai to Offer Air Disc Brakes

2018-07-09 zacks
WABCO Holdings Inc. (WBC - Free Report) signed a contract with South Korea-based commercial vehicle manufacturer, Hyundai Motor Company. Per the long-term agreement, WABCO will supply its single-piston air disc brake (ADB) technology, MAXX, for the manufacturing of Hyundai’s new medium-duty trucks, which are expected to start from August 2019.
FOXF WBC HYUO TM 7203 TYT CVRR HYUP LKQ TOYOF HYUD

7
German Cars and American Steak: Early Trade War Victims Emerge - Bloomberg

2018-07-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
HYUO NKE TM 7203 TYT HYUP DDAIF TOYOF HYUD

0
“Big Three” Korean Shipbuilders in a World of Overcapacity and Collapsed Orders

2018-07-08 wolfstreet
Worldwide orders for newly built commercial vessels peaked in 2007 at 85.3 million Compensated Gross Tonnage (CGT) and have never recovered, despite the boom in the intercontinental maritime trade, especially with East Asia. After a historic collapse in 2016, orders ticked up in 2017, but to a still desperately low 20.2 million CGT (new shipbuilding orders via Sea Europe):
HYUO HYUP HYUD

14
Ford slides deeper into China rut after worst ever first half vehicle sales

2018-07-06 malaymail
BEIJING, July 6 — Ford Motor’s China slump intensified, with vehicle sales tumbling 38 per cent in June and the automaker recording its worst-ever first half, as buyers shunned its aging models that are awaiting overhauls and flocked to rivals.
HYUO TM UG TYT KIMTY TOYOF HYUD GM.WS.A KIMTF GM.WS.B GM.WS.C 7203 HYUP GM GM.WSB

14
Ford slides deeper into China rut after worst ever first half vehicle sales

2018-07-06 channelnewsasia
Ford Motor’s China slump intensified, with vehicle sales tumbling 38 percent in June and the automaker recording its worst-ever first half, as buyers shunned its aging models that are awaiting overhauls and flocked to rivals.
HYUO TM UG TYT KIMTY TOYOF HYUD GM.WS.A KIMTF GM.WS.B GM.WS.C 7203 HYUP GM GM.WSB

0
S.Korean stocks, won edge higher; U.S. tariffs kick in

2018-07-06 reuters
SEOUL, July 6 (Reuters) - Round-up of South Korean financial markets: ** South Korea’s KOSPI stock index and the won gained on Friday after Washington imposed tariffs on more than 800 goods from China worth $34 billion, a decision investors fear could stoke a full-scale trade war. Bond yields rose. ** Tensions between the United States and China escalated as China’s commerce ministry said on Friday that China has no choice but to fight back against U.
HYUO KIMTF BC94 SMSN HYUP KIMTY HYUD SMSD

1
WABCO Signs Largest Ever Contract in South Korea; New Long-Term Agreement with Hyundai Motor Company to Supply Industry’s Lightest and Highest Performing Single-Piston Air Disc Brakes

2018-07-05 globenewswire
SHANGHAI, China, July 05, 2018 (GLOBE NEWSWIRE) -- WABCO Holdings Inc. (NYSE:WBC) (www.wabco-auto.com), a leading global supplier of technologies and services that improve the safety, efficiency and connectivity of commercial vehicles, today announced its largest ever contract in South Korea. Under the long-term agreement with Hyundai Motor Company, South Korea’s leading manufacturer of commercial vehicles, WABCO will supply its breakthrough MAXX™ single-piston air disc brake technology for series production on Hyundai’s new medium-duty trucks starting in August 2019.
WBC HYUO HYUP HYUD

0
Asia's Vulnerability to U.S. Car Tariffs in Five Easy Pieces - Bloomberg

2018-07-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
7261 MZDAY HYUO KIMTF TM MZDAF 7203 TYT HYUP KIMTY TOYOF HYUD

0
The Most Overlooked Renewable Energy Source

2018-07-04 oilprice
Tsvetana is a writer for the U.S.-based Divergente LLC consulting firm with over a decade of experience writing for news outlets such as iNVEZZ and…
ITMPF HYUO HYUP ITM HYUD

23
Xi faces hurdles bashing U.S. brands in a Trump trade war

2018-07-04 theedgemarkets
(July 4): As a trade war looms, one of Chinese President Xi Jinping’s biggest weapons could be boycotts of American brands by his country’s legion of consumers.
CTPCF DB HYUO YUMC CHLKF TM TYT TOYOF HYUD 0941 CHL MU 7203 UMC HYUP DIS

22
Xi Faces Hurdles Bashing U.S. Brands in a Trump Trade War

2018-07-04 bworldonline
As a trade war looms, one of Chinese President Xi Jinping’s biggest weapons could be boycotts of American brands by his country’s legion of consumers.
CTPCF DB HYUO YUMC CHLKF TM TYT TOYOF HYUD 0941 CHL MU 7203 UMC HYUP DIS

16
Xi faces hurdles bashing US brands in a Trump trade war

2018-07-03 malaymail
BEIJING, July 4 — As a trade war looms, one of Chinese President Xi Jinping’s biggest weapons could be boycotts of American brands by his country’s legion of consumers.
CTPCF DB HYUO YUMC CHLKF TM TYT TOYOF HYUD 0941 CHL 7203 HYUP DIS

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

12h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

13h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...